Malcolm Macartney

1.4k total citations · 1 hit paper
19 papers, 1.1k citations indexed

About

Malcolm Macartney is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Malcolm Macartney has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 11 papers in Epidemiology and 8 papers in Virology. Recurrent topics in Malcolm Macartney's work include HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (8 papers) and Hepatitis C virus research (6 papers). Malcolm Macartney is often cited by papers focused on HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (8 papers) and Hepatitis C virus research (6 papers). Malcolm Macartney collaborates with scholars based in United Kingdom, United States and Belgium. Malcolm Macartney's co-authors include Paul Griffin, Patrick Dorr, Mike Westby, Carolyn Napier, Manos Perros, Blanda Stammen, Anthony Wood, Caroline Smith‐Burchnell, Rob Webster and David A. Price and has published in prestigious journals such as Methods in enzymology on CD-ROM/Methods in enzymology, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Malcolm Macartney

18 papers receiving 1.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity

2005 909 citations Patrick Dorr, Mike Westby et al. Antimicrobial Agents and Chemotherapy profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Malcolm Macartney	663	523	284	217	213	19	1.1k
Patrick Dorr	930 1.4×	705 1.3×	409 1.4×	337 1.6×	198 0.9×	17	1.4k
Caroline Smith‐Burchnell	947 1.4×	727 1.4×	348 1.2×	337 1.6×	202 0.9×	12	1.4k
Serena Xu	818 1.2×	576 1.1×	325 1.1×	529 2.4×	142 0.7×	14	1.1k
T.M. Jenkins	698 1.1×	585 1.1×	338 1.2×	177 0.8×	149 0.7×	11	1.0k
Hirotomo Nakata	835 1.3×	805 1.5×	351 1.2×	242 1.1×	207 1.0×	29	1.3k
Guillaume Mousseau	742 1.1×	457 0.9×	464 1.6×	194 0.9×	140 0.7×	22	1.1k
Hiromi Ogata	384 0.6×	384 0.7×	291 1.0×	211 1.0×	102 0.5×	22	902
Gail Skowron	693 1.0×	693 1.3×	152 0.5×	192 0.9×	332 1.6×	45	1.2k
Arevik Mosoian	403 0.6×	211 0.4×	215 0.8×	314 1.4×	327 1.5×	25	1.1k
Magdeleine Hung	532 0.8×	622 1.2×	456 1.6×	192 0.9×	520 2.4×	38	1.4k

Countries citing papers authored by Malcolm Macartney

Since Specialization

Citations

This map shows the geographic impact of Malcolm Macartney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malcolm Macartney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malcolm Macartney more than expected).

Fields of papers citing papers by Malcolm Macartney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malcolm Macartney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malcolm Macartney. The network helps show where Malcolm Macartney may publish in the future.

Co-authorship network of co-authors of Malcolm Macartney

This figure shows the co-authorship network connecting the top 25 collaborators of Malcolm Macartney. A scholar is included among the top collaborators of Malcolm Macartney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malcolm Macartney. Malcolm Macartney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Aldhouse, Natalie V. J., Helen Kitchen, Malcolm Macartney, et al.. (2024). A conceptual model for chronic hepatitis B and content validity of the Hepatitis B Quality of Life (HBQOL) instrument. Journal of Patient-Reported Outcomes. 8(1). 29–29.

Menon, Sonia, Neha Agarwal, Jorne Lionel Biccler, et al.. (2023). Geographic and Population Distributions of Human Immunodeficiency Virus (HIV)–1 and HIV-2 Circulating Subtypes: A Systematic Literature Review and Meta-analysis (2010–2021). The Journal of Infectious Diseases. 228(11). 1583–1591. 38 indexed citations

Wilkinson, Tom, et al.. (2023). Burden of respiratory syncytial virus in adults in the United Kingdom: A systematic literature review and gap analysis. Influenza and Other Respiratory Viruses. 17(9). e13188–e13188. 12 indexed citations

Psomas, Christina, Sarah Fidler, Malcolm Macartney, et al.. (2018). Highlights from the 22nd International AIDS Conference (AIDS 2018), 22–27 July 2018, Amsterdam, the Netherlands. Journal of Virus Eradication. 4(4). 238–247. 4 indexed citations

Kadambari, Seilesh, Claire Atkinson, Suzanne Luck, et al.. (2016). Characterising variation in five genetic loci of cytomegalovirus during treatment for congenital infection. Journal of Medical Virology. 89(3). 502–507. 6 indexed citations

McCormick, Adele, Malcolm Macartney, Colette Smith, et al.. (2015). Evaluation of sequencing of HCV core/E1, NS5A and NS5B as a genotype predictive tool in comparison with commercial assays targeting 5′UTR. Journal of Clinical Virology. 66. 56–59. 14 indexed citations

Calisti, G, Malcolm Macartney, Adele McCormick, et al.. (2015). IL28B genotype predicts response to chronic hepatitis C triple therapy with telaprevir or boceprevir in treatment naïve and treatment-experienced patients other than prior partial- and null-responders. SpringerPlus. 4(1). 357–357. 8 indexed citations

Macartney, Malcolm, et al.. (2015). Anaplasmosis in a dog on Vancouver Island.. PubMed. 56(7). 761–2. 1 indexed citations

Macartney, Malcolm, Dianne Irish, Simon H. Bridge, et al.. (2014). Telaprevir or boceprevir based therapy for chronic hepatitis C infection: Development of resistance-associated variants in treatment failure. Antiviral Research. 105. 112–117. 10 indexed citations

10.

Macartney, Malcolm, Felix Feyertag, Colette Smith, et al.. (2014). The utility of different bioinformatics algorithms for genotypic HIV-1 tropism testing in a large clinical cohort with multiple subtypes. AIDS. 28(11). 1611–1617. 5 indexed citations

11.

Booth, Clare, Adele McCormick, Ana Garcı́a-Dı́az, et al.. (2014). Feasibility of testing and detection of HIV-1 drug resistance in proviral DNA. BMC Infectious Diseases. 14(S4). 1 indexed citations

12.

Wyatt, Harry J., Malcolm Macartney, Tim Conibear, et al.. (2014). The utility of genotypic tropism testing in clinical practice. International Journal of STD & AIDS. 26(8). 593–594. 1 indexed citations

13.

McCormick, Adele, Lawrence Wang, Ana Garcı́a-Dı́az, et al.. (2014). Prevalence of Baseline Polymorphisms for Potential Resistance to NS5A Inhibitors in Drug-Naive Individuals Infected with Hepatitis C Genotypes 1–4. Antiviral Therapy. 20(1). 81–85. 11 indexed citations

14.

Garcı́a-Dı́az, Ana, Adele McCormick, Malcolm Macartney, et al.. (2013). Evaluation of the Roche prototype 454 HIV-1 ultradeep sequencing drug resistance assay in a routine diagnostic laboratory. Journal of Clinical Virology. 58(2). 468–473. 5 indexed citations

15.

Able, Sarah, Paul Griffin, Ian James, et al.. (2009). Chapter 2 CCR5 Pharmacology Methodologies and Associated Applications. Methods in enzymology on CD-ROM/Methods in enzymology. 460. 17–55. 13 indexed citations

16.

Dorr, Patrick, Mike Westby, Paul Griffin, et al.. (2005). Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity. Antimicrobial Agents and Chemotherapy. 49(11). 4721–4732. 909 indexed citations breakdown →

17.

Macartney, Malcolm, et al.. (2003). Reptiles of the Northwest: California to Alaska: Rockies to the Coast. Northwestern Naturalist. 84(1). 46–46. 4 indexed citations

18.

Torre, Francesco, Philip Wong, Malcolm Macartney, Roger Williams, & Nikolai V. Naoumov. (1999). Evolution of wild-type and precore mutant HBV infection after liver transplantation. Journal of Medical Virology. 59(1). 5–13. 2 indexed citations

19.

Macartney, Malcolm, Edward Gane, Bernard Portmann, & Roger Williams. (1997). COMPARISON OF A NEW QUANTITATIVE CYTOMEGALOVIRUS DNA ASSAY WITH OTHER DETECTION METHODS. Transplantation. 63(12). 1803–1807. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact